Canlyniadau Chwilio - Emilio Suárez
- Dangos 1 - 4 canlyniadau o 4
-
1
-
2
Tenofovir Is Effective Alone or With Emtricitabine in Adefovir-Treated Patients With Chronic-Hepatitis B Virus Infection gan Thomas Berg, Patrick Marcellin, Fabien Zoulim, Bernd Möller, Huy N. Trinh, Sing Chan, Emilio Suárez, Fabien Lavocat, Andrea Snow‐Lampart, David Frederick, J. Sorbel, Katyna Borroto–Esoda, David Oldach, Franck Rousseau
Cyhoeddwyd 2010Artigo -
3
Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens... gan Marı́a Buti, María Luisa Manzano, Rosa M. Morillas, Montserrat García–Retortillo, Leticia Martín, M. Prieto, María Luisa Gutiérrez García, Emilio Suárez, Mariano Gómez Rubio, Javier López, Pilar Castillo, Manuel Rodríguez, José Manuel Zozaya, Miguel Ángel Simón, Luís Morano, José Luís Calleja, Mireia Yébenes, Rafael Esteban
Cyhoeddwyd 2017Artigo -
4
Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients gan Manuel Romero‐Gómez, María del Mar Viloria, Raúl J. Andrade, Javier Salmerón, M. Diago, Conrado Fernández‐Rodríguez, Raquel Corpas, Marina Cruz, Lourdes Grande, Luis Alberto Vázquez, Paloma Muñoz‐de‐Rueda, Pilar López Serrano, A. Gila, María Luisa Gutiérrez García, Celia Pérez, A. Ruiz‐Extremera, Emilio Suárez, Jesús Castillo
Cyhoeddwyd 2005Artigo
Offerynnau Chwilio:
Pynciau Perthynol
Internal medicine
Medicine
Virus
Gastroenterology
Hepatitis B
Hepatitis B virus
Virology
Adverse effect
Chronic hepatitis
Lamivudine
Ribavirin
Adefovir
Clinical endpoint
Combination therapy
Emtricitabine
Entecavir
Environmental health
HBsAg
Hepatocellular carcinoma
Immunology
Insulin
Insulin resistance
Liver disease
Lymphoma
Pegylated interferon
Population
Randomized controlled trial
Rituximab
Tolerability
Vaccination